VALENTINA V. RUCKER
VALENTINA V. RUCKERAssociate
Antitrust
Privacy & Data Security
Valentina Rucker is an associate in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati. Valentina's practice encompasses a wide variety of antitrust matters, including mergers and acquisitions, joint ventures, investigations by the United States Department of Justice and the Federal Trade Commission, private litigation, and counseling on issues such as resale price maintenance and antitrust compliance. She has also represented clients in government investigations and enforcement actions related to export controls.
In addition, Valentina's practice includes advising clients on privacy and data security issues. She has represented several clients before the FTC in matters relating to privacy concerns and advises clients regarding the adequacy of their data security practices.
Valentina's client base spans the software, pharmaceutical, videoconferencing/telepresence, gaming, laser, retail, beverage, semiconductor, speech recognition, and media industries.
Valentina is an active member of the American Bar Association's Section of Antitrust Law. She is currently serving as the Antitrust Section's liaison to the Russian and CIS Antitrust ABA organizations, as well as running a series of "Recent Developments" programs for the Health Care and Pharmaceuticals Committee. Valentina was previously a co-editor of the Recent Developments newsletter, a publication of the Health Care and Pharmaceuticals Committee.
EDUCATION:
- J.D., Howard University School of Law, 2007
Magna Cum Laude; Graduated First in Class; Senior Publications Editor, Howard Law Journal - B.S., International Business, Wichita State University, 2003
Summa Cum Laude, Minors in Economics and Marketing
- Member, International Association of Privacy Professionals
- Co-author with S. Williams, J. Jacobson, and S. Silber, "FTC v. Actavis: 'Reverse Payments'—Not Presumptively Lawful, Not Presumptively Unlawful, But Subject to a Rule-of-Reason Analysis," WSGR Alert, June 18, 2013
- Co-author with G. Zakharov, "Regulation of Vertical Restraints in Russia and the U.S.," Legal Insight, No. 2, March 2013 (in Russian)
- Co-author with D. Kane, "Competition Tunnel Vision: Russia's Narrow Interpretation of Dominance," Antitrust Health Care Chronicle, Vol. 26, No. 1, September 2012
- Co-author with D. Kane, "FTC Settles with Facebook and Will Review Its Practice of Allowing Companies to Settle Charges of Wrongdoing While Denying the Violations Occurred," Eye on Privacy, Wilson Sonsini Goodrich & Rosati, September 2012
- Co-author with D. Kane, L. Parnes, and S. Silber, "California Steps Up Privacy Efforts with New Privacy Enforcement and Protection Unit," WSGR Alert, July 25, 2012
- Co-author with D. Kane, "Forewarned is Forearmed: Pharmaceutical Companies Considering Distribution Networks in Russia Should Take Heed of the Novo Nordisk Experience," Part I and Part II, New Pharma Thinkers, June 2012
- Co-author with T. Klausner and L. Parnes, "Federal Trade Commission Announces Settlement in Online Behavioral Advertising Case," WSGR Alert, March 16, 2011
- Co-author with V. Rudomino, "Third Time's the Charm?: Russian Federal Antimonopoly Service Presents Its Third Antimonopoly Package," International Antitrust Bulletin, ABA Section of Antitrust Law, International Committee, Volume 4, 2010
- Co-author with S. Sher, "Post-Close Caution: Antitrust Agencies Challenge Two Consummated Mergers," The Threshold, Vol. IX, No. 2, Spring 2009
- Co-author with J. Wolman, "The FTC Roundtable on Follow-on Biologics Drugs: Framework for Competition and Continued Innovation," Antitrust Health Care Chronicle, Vol. 22, No. 3, February 2009
- Co-author with J. Jacobson, "Whither Price Squeeze Antitrust?" Global Competition Policy, No. 1, January 2008
- Panel Moderator, "Health and Pharmaceuticals Committee: Recent Developments Series December 2012 - January 2013," Washington, D.C., February 12, 2013
- Panel Moderator, "Recent Antitrust Developments in the Health Care and Pharmaceuticals Markets: October and November 2012," ABA Section of Antitrust Law program, Washington, D.C., December 6, 2012
- Panel Moderator, "Recent Antitrust Developments in the Health Care and Pharmaceuticals Markets: August and September 2012," ABA Section of Antitrust Law program, Washington, D.C., October 17, 2012
- Panel Moderator, "Recent Antitrust Developments in the Health Care and Pharmaceuticals Markets: June and July 2012," ABA Section of Antitrust Law program, Washington, D.C., August 12, 2012
- Guest Lecturer, Antitrust, Howard University School of Law, Fall 2012
- Panel Moderator, "Recent Antitrust Developments in the Health Care and Pharmaceuticals Markets: April and May 2012," ABA Section of Antitrust Law program, Washington, D.C., June 13, 2012
- Speaker, "U.S. Practitioner's Perspective: Pharmaceuticals Roundtable with the Federal Antimonopoly Service" (part of the Russian Antitrust Enforcers' Study Tour 2012), Washington, D.C., February 2, 2012
- Moderator, "Brick by Brick: BRIC Countries Build Their Antitrust Regimes Through Institutional Changes and Active Enforcement," ABA International Committee Webinar, June 2011
- Panelist, "Why Antitrust?" ABA Section of Antitrust Law and Howard University School of Law program, Washington, D.C., March 24, 2011
- Bar of the District of Columbia
- State Bar of New York
